Dr. Mederos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UCLA
Los Angeles, CA 90095- Is this information wrong?
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 2018 - 2024
- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Surgery, 2017 - 2018
- Baylor College of MedicineClass of 2017
- University of Texas - Pan AmericanBS, Biology, Summa cum laude, 2009 - 2013
Certifications & Licensure
- CA State Medical License Current
Awards, Honors, & Recognition
- Alpha Omega Alpha 2017
Publications & Presentations
PubMed
- Neoadjuvant chemotherapy is associated with improved disease-free survival in pancreatic cancer patients undergoing pancreaticoduodenectomy with vascular resection.Dustin L Dillon, Joon Y Park, Joe Hines, Michael A Mederos, Young-Ji Seo, Jonathan King, Timothy Donahue, Mark D Girgis> ;Journal of Surgical Oncology. 2024 May 10
- Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumors Have Similar Disease-Specific Survival Outcome.Sarah Mirzaie, Joon Y Park, Michael A Mederos, Mark D Girgis> ;Journal of Gastrointestinal Surgery. 2023 Nov 1
- Laparoscopic compared to open approach for distal gastrectomy may reduce pneumonia risk for patients with gastric cancer.Kyle D Klingbeil, Michael Mederos, Joon Y Park, Young-Ji Seo, Daniela Markovic, Victor Chui, Mark Girgis, Brian E Kadera> ;Surgery Open Science. 2023 Aug 1
- Join now to see all
Press Mentions
- Disparities in Referral to High-Volume Pancreatic Cancer Treatment Centers Impact SurvivalFebruary 14th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: